Zevra Therapeutics, Inc. Stock-Based Compensation
Zevra Therapeutics, Inc. (ZVRA) reported Stock-Based Compensation of $6.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- Zevra Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.97M, a 20.50% increase year-over-year.
- Zevra Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.10M, a 0.32% decline year-over-year.
- Zevra Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $4.28M, a 6.62% increase year-over-year.
- Zevra Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.77M, a 54.85% decline year-over-year.
- Zevra Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $12.63M, a 15.24% decline from fiscal 2024.
- Zevra Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $14.91M, a 150.35% increase from fiscal 2023.
- Zevra Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $5.95M, a 38.66% increase from fiscal 2022.
- Zevra Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $4.29M, a 76.27% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.07M 10-Q · filed 2026-08-05 | $10.36M derived: sum of 3 quarters · filed 2026-08-05 | $13.13M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $3.10M 10-Q · filed 2026-05-06 | $7.39M derived: sum of 2 quarters · filed 2026-05-06 | $10.16M derived: sum of 3 quarters · filed 2026-05-06 | $12.62M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $7.05M derived: sum of 2 quarters · filed 2026-03-09 | $9.52M derived: sum of 3 quarters · filed 2026-08-05 | $12.63M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.24M derived: sum of 2 quarters · filed 2026-08-05 | $8.35M 10-Q · filed 2025-11-05 | $12.37M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.58M 10-Q · filed 2026-08-05 | $9.60M derived: sum of 3 quarters · filed 2026-08-05 | $15.73M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | $3.12M 10-Q · filed 2026-05-06 | $7.13M derived: sum of 2 quarters · filed 2026-05-06 | $13.27M derived: sum of 3 quarters · filed 2026-05-06 | $15.90M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $10.15M derived: sum of 2 quarters · filed 2026-03-09 | $12.79M derived: sum of 3 quarters · filed 2026-03-09 | $14.91M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $6.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $8.77M derived: sum of 2 quarters · filed 2025-11-05 | $10.89M 10-Q · filed 2025-11-05 | $12.36M derived: sum of 4 quarters · filed 2025-11-05 | |||
| 2024-06-30 | $2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $4.75M 10-Q · filed 2025-08-12 | $6.22M derived: sum of 3 quarters · filed 2025-08-12 | $7.61M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $2.12M 10-Q · filed 2025-05-13 | $3.59M derived: sum of 2 quarters · filed 2025-05-13 | $4.98M derived: sum of 3 quarters · filed 2025-05-13 | $7.13M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $2.86M derived: sum of 2 quarters · filed 2025-03-12 | $5.01M derived: sum of 3 quarters · filed 2025-03-12 | $5.95M 10-K · filed 2025-03-12 | |||
| 2023-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $3.54M derived: sum of 2 quarters · filed 2024-11-13 | $4.48M 10-Q · filed 2024-11-13 | $3.08M 10-Q · filed 2023-11-07 | $5.44M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $3.10M 10-Q · filed 2024-08-14 | $1.69M 10-Q · filed 2023-08-14 | $4.05M derived: sum of 3 quarters · filed 2024-08-14 | $4.96M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $945.00K 10-Q · filed 2024-05-09 | $591.00K 10-Q · filed 2023-05-15 | $1.90M derived: sum of 2 quarters · filed 2024-05-09 | $2.81M derived: sum of 3 quarters · filed 2024-05-09 | $4.32M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $955.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.87M derived: sum of 2 quarters · filed 2024-04-01 | $3.38M derived: sum of 3 quarters · filed 2024-04-01 | $4.29M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $911.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.42M derived: sum of 2 quarters · filed 2023-11-07 | $3.34M 10-Q · filed 2023-11-07 | $4.16M derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.43M 10-Q · filed 2023-08-14 | $3.25M derived: sum of 3 quarters · filed 2023-08-14 | $3.87M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $918.00K 10-Q · filed 2023-05-15 | $1.74M derived: sum of 2 quarters · filed 2023-05-15 | $2.36M derived: sum of 3 quarters · filed 2023-05-15 | $2.68M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $823.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $1.44M derived: sum of 2 quarters · filed 2023-03-07 | $1.76M derived: sum of 3 quarters · filed 2023-03-07 | $2.44M 10-K · filed 2023-03-07 | |||
| 2021-09-30 | $620.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $938.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.61M 10-Q · filed 2022-11-10 | $2.07M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $318.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $993.00K 10-Q · filed 2022-08-12 | $1.45M derived: sum of 3 quarters · filed 2022-08-12 | $1.83M derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $675.00K 10-Q · filed 2022-05-12 | $1.13M derived: sum of 2 quarters · filed 2022-05-12 | $1.52M derived: sum of 3 quarters · filed 2022-05-12 | $2.14M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $457.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $842.00K derived: sum of 2 quarters · filed 2022-03-31 | $1.46M derived: sum of 3 quarters · filed 2022-03-31 | $2.49M 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $385.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.00M derived: sum of 2 quarters · filed 2021-11-10 | $2.03M 10-Q · filed 2021-11-10 | $2.78M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $620.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $1.65M 10-Q · filed 2021-08-13 | $2.40M derived: sum of 3 quarters · filed 2021-08-13 | $3.45M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $1.03M 10-Q · filed 2021-05-14 | $1.77M derived: sum of 2 quarters · filed 2021-05-14 | $2.83M derived: sum of 3 quarters · filed 2021-05-14 | $4.15M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $746.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.80M derived: sum of 2 quarters · filed 2021-03-12 | $3.12M derived: sum of 3 quarters · filed 2021-03-12 | $4.41M 10-K · filed 2021-03-12 | |||
| 2019-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $2.37M derived: sum of 2 quarters · filed 2020-10-30 | $3.66M 10-Q · filed 2020-10-30 | $4.91M derived: sum of 4 quarters · filed 2020-10-30 | |||
| 2019-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $2.61M 10-Q · filed 2020-08-12 | $3.86M derived: sum of 3 quarters · filed 2020-08-12 | $6.44M derived: sum of 4 quarters · filed 2020-08-12 | |||
| 2019-03-31 | $1.29M 10-Q · filed 2020-05-13 | $2.54M derived: sum of 2 quarters · filed 2020-05-13 | $5.13M derived: sum of 3 quarters · filed 2020-05-13 | $6.50M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $3.84M derived: sum of 2 quarters · filed 2020-02-28 | $5.21M derived: sum of 3 quarters · filed 2020-02-28 | $6.50M 10-K · filed 2020-02-28 | |||
| 2018-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $3.96M derived: sum of 2 quarters · filed 2019-11-14 | $5.25M 10-Q · filed 2019-11-14 | $6.39M derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $2.66M 10-Q · filed 2019-08-13 | $3.81M derived: sum of 3 quarters · filed 2019-08-13 | $4.97M derived: sum of 4 quarters · filed 2019-08-13 | |||
| 2018-03-31 | $1.28M 10-Q · filed 2019-05-14 | $2.43M derived: sum of 2 quarters · filed 2019-05-14 | $3.59M derived: sum of 3 quarters · filed 2019-05-14 | $4.75M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $2.31M derived: sum of 2 quarters · filed 2019-03-01 | $3.47M derived: sum of 3 quarters · filed 2019-03-01 | $4.56M 10-K · filed 2019-03-01 | |||
| 2017-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $2.32M derived: sum of 2 quarters · filed 2018-11-09 | $3.41M 10-Q · filed 2018-11-09 | $4.45M derived: sum of 4 quarters · filed 2018-11-09 | |||
| 2017-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $2.25M 10-Q · filed 2018-08-10 | $3.30M derived: sum of 3 quarters · filed 2018-08-10 | $6.58M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2017-03-31 | $1.09M 10-Q · filed 2018-05-11 | $2.13M derived: sum of 2 quarters · filed 2018-05-11 | $5.41M derived: sum of 3 quarters · filed 2018-05-11 | $6.67M derived: sum of 4 quarters · filed 2018-05-11 | |||
| 2016-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $4.32M derived: sum of 2 quarters · filed 2018-03-30 | $5.58M derived: sum of 3 quarters · filed 2018-03-30 | $6.60M 10-K · filed 2018-03-30 | |||
| 2016-09-30 | $3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $4.54M derived: sum of 2 quarters · filed 2017-11-09 | $5.56M 10-Q · filed 2017-11-09 | $6.47M derived: sum of 4 quarters · filed 2018-03-30 | |||
| 2016-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $2.28M 10-Q · filed 2017-08-10 | $3.19M derived: sum of 3 quarters · filed 2018-03-30 | $3.68M derived: sum of 4 quarters · filed 2018-03-30 | |||
| 2016-03-31 | $1.02M 10-Q · filed 2017-05-22 | $1.94M derived: sum of 2 quarters · filed 2018-03-30 | $2.43M derived: sum of 3 quarters · filed 2018-03-30 | $3.30M derived: sum of 4 quarters · filed 2018-03-30 | |||
| 2015-12-31 | $913.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $1.41M derived: sum of 2 quarters · filed 2018-03-30 | $2.28M derived: sum of 3 quarters · filed 2018-03-30 | $2.37M 10-K · filed 2018-03-30 | |||
| 2015-09-30 | $492.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.36M derived: sum of 2 quarters · filed 2016-11-10 | $1.46M 10-Q · filed 2016-11-10 | $1.50M derived: sum of 4 quarters · filed 2017-03-10 | |||
| 2015-06-30 | $873.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $964.00K 10-Q · filed 2016-08-11 | $1.01M derived: sum of 3 quarters · filed 2017-03-10 | $1.06M derived: sum of 4 quarters · filed 2017-03-10 | |||
| 2015-03-31 | $91.00K 10-Q · filed 2016-05-13 | $136.00K derived: sum of 2 quarters · filed 2017-03-10 | $188.00K derived: sum of 3 quarters · filed 2017-03-10 | $279.00K derived: sum of 4 quarters · filed 2017-03-10 | |||
| 2014-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $97.00K derived: sum of 2 quarters · filed 2017-03-10 | $188.00K derived: sum of 3 quarters · filed 2017-03-10 | $214.00K 10-K · filed 2017-03-10 | |||
| 2014-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $143.00K derived: sum of 2 quarters · filed 2015-11-13 | $169.00K 10-Q · filed 2015-11-13 | ||||
| 2014-06-30 | $91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $117.00K 10-Q · filed 2015-08-14 | |||||
| 2014-03-31 | $26.00K 10-Q · filed 2015-05-29 | ||||||
| 2013-12-31 | $134.00K 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |